Interaction between substrates suggests a relationship between organophosphorus-sensitive phenylvalerate- and

Mónica Benabent1, Eugenio Vilanova1, Iris Mangas1

  • 1University "Miguel Hernandez", Institute of Bioengineering, Unit of Toxicology, Elche, Spain.

Toxicology Letters
|March 1, 2014
PubMed

Insights

Organophosphorus compounds target esterases. This study found that phenylvalerate esterase (PVase) activity in chicken brains interacts with acetylcholine-hydrolyzing activity, suggesting a shared protein component.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • Organophosphorus compounds (OPs) are known neurotoxins that inhibit esterases like acetylcholinesterase (AChE) and neuropathy target esterase (NTE).
  • OPs also interact with other esterases, whose biological functions remain largely unknown.
  • Chicken brain fractions exhibit three distinct phenylvalerate esterase (PVase) activities: Eα, Eβ, and Eγ.

Purpose of the Study:

  • To investigate the relationship between phenylvalerate esterase (PVase) activity and acetylcholine-hydrolyzing activity in chicken brain fractions.
  • To determine if PVase components share substrates or interact with known acetylcholine-hydrolyzing enzymes.

Main Methods:

  • Kinetically discriminating three PVase components (Eα, Eβ, Eγ) in soluble chicken brain fractions.
  • Assessing the effect of acetylthiocholine (AChE substrate) on Eα PVase activity and phenylvalerate on AChE activity.
  • Evaluating the impact of mipafox (an organophosphate) on Eβ PVase activity and its interaction with acetylthiocholine hydrolysis.

Main Results:

  • Eα PVase activity was inhibited by acetylthiocholine in a non-competitive manner, while acetylthiocholine hydrolysis was competitively inhibited by phenylvalerate.
  • Eβ PVase activity was unaffected by acetylthiocholine, but acetylthiocholine hydrolysis was competitively inhibited by phenylvalerate.
  • These interactions suggest a potential overlap in the protein targets of PVase and AChE.

Conclusions:

  • A portion of phenylvalerate esterase (PVase) activity in chicken brains may involve proteins that also hydrolyze acetylthiocholine.
  • This finding highlights a potential novel interaction relevant to organophosphorus compound toxicity mechanisms.
  • Further research is warranted to fully elucidate the functional significance of these shared esterase activities.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.7K
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
1.3K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K